This compound is primarily utilized in the field of asymmetric synthesis and catalysis. It serves as a chiral ligand or catalyst in various organic reactions, particularly in the synthesis of enantiomerically pure compounds. Its structure, featuring a trifluoromethyl group and a benzenesulfonamide moiety, enhances its ability to induce stereoselectivity in reactions such as hydrogenation, carbon-carbon bond formation, and other transformations. This makes it valuable in the pharmaceutical industry for producing chiral drugs and intermediates with high enantiomeric purity. Additionally, it may find use in academic research for developing new methodologies in asymmetric catalysis.